PLCO Publications
Here you can browse the complete list of publications for PLCO
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| Coffee Consumption and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma by Sex: The Liver Cancer Pooling Project. | 26126626 | Petrick JL, Freedman ND, Graubard BI, Sahasrabuddhe VV, Lai GY, Alavanja MC, Beane-Freeman LE, Boggs DA, Buring JE, Chan AT, Chong DQ, Fuchs CS, Gapstur SM, Gaziano JM, Giovannucci EL, Hollenbeck AR, King LY, Koshiol J, Lee IM, Linet MS, Palmer JR, … | Cancer Epidemiol. Biomarkers Prev. | 2015 | PLCO |
| Polybrominated diphenyl ethers and thyroid cancer risk in the Prostate, Colorectal, Lung, and Ovarian Cancer Screening Trial cohort. | 25939348 | Aschebrook-Kilfoy B, DellaValle CT, Purdue M, Kim C, Zhang Y, Sjodin A, Ward MH | American journal of epidemiology | 2015 | PLCO |
| Mitochondrial DNA copy number and chronic lymphocytic leukemia/small lymphocytic lymphoma risk in two prospective studies. | 25293880 | Kim C, Bassig BA, Seow WJ, Hu W, Purdue MP, Huang WY, Liu CS, Cheng WL, Männistö S, Vermeulen R, Weinstein SJ, Lim U, Hosgood HD, Bonner MR, Caporaso NE, Albanes D, Lan Q, Rothman N | Cancer Epidemiol Biomarkers Prev | 2015 | PLCO |
| Risk of follicular lymphoma associated with BCL2 translocations in peripheral blood. | 25549806 | Hirt C, Camargo MC, Yu KJ, Hewitt SM, Dölken G, Rabkin CS | Leuk Lymphoma | 2015 | PLCO |
| Vitamin D-binding protein and pancreatic cancer: a nested case-control study. | 25904602 | Piper MR, Freedman DM, Robien K, Kopp W, Rager H, Horst RL, Stolzenberg-Solomon RZ | Am J Clin Nutr | 2015 | PLCO |
| A prospective evaluation of C-peptide levels and colorectal adenoma incidence. | 25592235 | Murphy N, Cross AJ, Huang WY, Rajabzadeh-Heshejin V, Stanczyk F, Hayes R, Gunter MJ | Cancer Epidemiol | 2015 | PLCO |
| Genome-wide association study of survival in patients with pancreatic adenocarcinoma. | 23180869 | Wu C, Kraft P, Stolzenberg-Solomon R, Steplowski E, Brotzman M, Xu M, Mudgal P, Amundadottir L, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Jacobs EJ, Kooperberg C, Petersen GM, Zheng W, Albanes D, Boutron-Ruault MC, Buring JE, Canzian F… | Gut | 2014 | PLCO |
| LINE1 methylation levels associated with increased bladder cancer risk in pre-diagnostic blood DNA among US (PLCO) and European (ATBC) cohort study participants. | 24316677 | Andreotti G, Karami S, Pfeiffer RM, Hurwitz L, Liao LM, Weinstein SJ, Albanes D, Virtamo J, Silverman DT, Rothman N, Moore LE | Epigenetics | 2014 | PLCO |
| Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial. | 24053621 | Pinsky PF, Parnes HL, Andriole G | BJU Int. | 2014 | PLCO |
| Body mass index and mortality among blacks and whites adults in the Prostate, Lung, Colorectal, and Ovarian (PLCO) cancer screening trial. | 23512729 | Xiao Q, Hsing AW, Park Y, Moore SC, Matthews CE, Berrington de González A, Kitahara CM | Obesity (Silver Spring) | 2014 | PLCO |
| Randomization to screening for prostate, lung, colorectal and ovarian cancers and thyroid cancer incidence in two large cancer screening trials. | 25192282 | O'Grady TJ, Kitahara CM, DiRienzo AG, Boscoe FP, Gates MA | PLoS ONE | 2014 | NLST, PLCO |
| Bladder cancer risk: Use of the PLCO and NLST to identify a suitable screening cohort. | 25044253 | Krabbe LM, Svatek RS, Shariat SF, Messing E, Lotan Y | Urol. Oncol. | 2014 | NLST, PLCO |
| Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials. | 24577803 | Meza R, ten Haaf K, Kong CY, Erdogan A, Black WC, Tammemagi MC, Choi SE, Jeon J, Han SS, Munshi V, van Rosmalen J, Pinsky P, McMahon PM, de Koning HJ, Feuer EJ, Hazelton WD, Plevritis SK | Cancer | 2014 | NLST, PLCO |
| Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. | 25460915 | Tammemägi MC, Church TR, Hocking WG, Silvestri GA, Kvale PA, Riley TL, Commins J, Berg CD | PLoS Med. | 2014 | NLST, PLCO |
| Analysis of serial ovarian volume measurements and incidence of ovarian cancer: implications for pathogenesis. | 25217774 | Bodelon C, Pfeiffer RM, Buys SS, Black A, Sherman ME | J. Natl. Cancer Inst. | 2014 | PLCO |
| Abnormal CA-125 levels in menopausal women without ovarian cancer. | 25127988 | Terada KY, Elia J, Kim R, Carney M, Ahn HJ | Gynecol. Oncol. | 2014 | PLCO |
| Interval lung cancers not detected on screening chest X-rays: How are they different? | 25123333 | Kvale PA, Johnson CC, Tammemägi M, Marcus PM, Zylak CJ, Spizarny DL, Hocking W, Oken M, Commins J, Ragard L, Hu P, Berg C, Prorok P | Lung Cancer | 2014 | PLCO |
| Non-compliance with the initial screening exam visit in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. | 25038532 | Marcus PM, Ogden SL, Gren LH, Childs JC, Pretzel SM, Lamerato LE, Walsh K, Rozjabek HM, Mabie J, Thomas B, Riley T | Prev Med | 2014 | PLCO |
| Diabetes and pancreatic cancer survival: a prospective cohort-based study. | 24786605 | Toriola AT, Stolzenberg-Solomon R, Dalidowitz L, Linehan D, Colditz G | Br. J. Cancer | 2014 | PLCO |
| Modified Gleason grade of prostatic adenocarcinomas detected in the PLCO cancer screening trial. | 24594407 | Humphrey PA, Hickey TP, Riley TL, Mabie JE, Bellinger A, Strother M, Andriole GL | J. Urol. | 2014 | PLCO |